BNLB.. $0.1045.. Bond Labs' NDS Nutrition Launches New

New Post Public Reply Private Reply Replies (0) Message Board

Feb 5, 2013 at 7:08 PM

BNLB.. $0.1045.. Bond Labs' NDS Nutrition Launches New Weight Loss Product

OMAHA, Neb.--(BUSINESS WIRE)-- Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through its wholly owned operating division, NDS Nutrition Products (“NDS”), is pleased to announce that the Company is introducing another new, cutting edge product, EvoLean™, to its impressive list of effective diet and weight loss formulations.

“New product innovation is an integral part of our ongoing growth strategy,” stated Bond Laboratories, Inc. CEO, John S. Wilson, “and NDS has a long-standing tradition of developing high-quality dietary and nutritional supplements. EvoLean™, which launches exclusively in GNC franchise locations this week, is yet another example of our commitment to product excellence.” EvoLean’s low-stimulant formula boosts metabolism through a powerful blend of four key ingredients, which have been profiled and highly-touted on television by respected medical professionals. Scott Steil of Nutra Bridge, the exclusive distributor of 7-Keto®, one of EvoLean’s key ingredients added, “We are thrilled to partner with NDS Nutrition to provide a revolutionary and efficacious dietary option to people that demand outstanding results in a low stimulant formula and look forward to working with NDS to deliver additional science-backed solutions in the future that deliver superior results to customers.”

“Our revenue growth is dependent on new product innovation and retail outlet expansion and we believe that EvoLean™ will be a strong enhancement to our already powerful line of sports nutrition and weight loss products, available both domestically and internationally, through the GNC® franchise system. GNC® currently has 1,624 international franchise operations in 56 countries as well as 928 domestic franchise stores. As you can imagine, we are thrilled to introduce another new, quality product into the multi-billion dollar weight loss category,” concluded Mr. Wilson.

About Bond Labs

Bond Laboratories is a manufacturer of innovative nutritional supplements. The Company produces and markets products through its NDS Nutrition division. NDS currently markets 48 products to over 900 GNC franchise locations domestically, and up to 10 products internationally to GNC franchise locations in six countries. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.

Forward-Looking Statement

Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company’s actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company’s ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company’s pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company’s filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078

Source: Bond Laboratories, Inc.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Key Players Depart No Makeup Makeup Amid Rapid Success

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Koppers Faces Investigation: Investors Cautious Amid Probe

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

DraftKings Faces Revenue Cutback; Legal Probe Begins

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Blue Owl Tech Faces Lawsuit Post-44% Share Dive

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Tenax Therapeutics Faces Legal Heat After Stock Plunge

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

NatGold Pulling NATG From MEXC Amid Security Concerns

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...